Johnson & Johnson Earnings Top, Dividend Hiked

Johnson & Johnson (JNJ) on Tuesday reported adjusted earnings of $2.59 per share on $22.3 billion in sales for its first quarter. In response, JNJ stock lost a fraction.


Analysts polled by Zacks Investment Research expected Johnson & Johnson to earn $2.31 per share on $21.82 billion in sales.

In the year-earlier period, J&J earned $2.30 per share and reported $20.7 billion in sales.

For the year ending in 2021, the Dow Jones pharmaceutical company guided to adjusted EPS of $9.42-$9.57 on sales of $90.6 billion – $91.6 billion. Analysts called for adjusted profit of $9.48 a share and $91.3 billion in sales.

J&J raised its quarterly dividend by 5 cents, or nearly 5%, to $1.06 a share.

Johnson & Johnson sees some resolution soon to its coronavirus vaccine, which has been suspended after the FDA and CDC called for a “pause” in the one-shot treatment.

In premarket trading on the stock market today, JNJ stock fell 0.3%. Shares are currently forming a flat base with a buy point at 173.75, according to

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


GlaxoSmithKline Surges On Report Activist Investor Takes ‘Significant’ Stake

Thermo Expands Its Biggest Business With $17.4 Billion PPD Buyout

See Stocks On The List Of Leaders Near A Buy Point

Watch IBD’s Investing Strategies Show For Actionable Market Insights

Find The Best Long-Term Investments With IBD Long-Term Leaders

Most Related Links :
reporterwings Governmental News Finance News

Source link

Back to top button